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Abstract
The unwelcome evolution of malignancy during cancer progression emerges
through a selection process in a complex heterogeneous population structure.
In the present work, we investigate evolutionary dynamics in a phenotypically
heterogeneous population of stem cells (SCs) and their associated progenitors.
The fate of a malignant mutation is determined not only by overall stem cell
and differentiated cell growth rates but also differentiation and dedifferentiation
rates. We investigate the effect of such a complex population structure on the
evolution of malignant mutations. We derive exact analytic results for the fixa-
tion probability of a mutant arising in each of the subpopulations. The analytic
results are in almost perfect agreement with the numerical simulations. More-
over, a condition for evolutionary advantage of a mutant cell versus the wild type
population is given in the present study. We also show that microenvironment-
induced plasticity in invading mutants leads to more aggressive mutants with
higher fixation probability. Our model predicts that decreasing polarity be-
tween stem and differentiated cells’ turnover would raise the survivability of
non-plastic mutants; while it would suppress the development of malignancy for
plastic mutants. We discuss our model in the context of colorectal/intestinal
cancer (at the epithelium). This novel mathematical framework can be applied
more generally to a variety of problems concerning selection in heterogeneous
populations, in other contexts such as population genetics, and ecology.
Keywords: cancer stem cell, evolutionary dynamics, phenotypic plasticity,
differentiation, de-differentiation, self-renewal, colorectal cancer.
Introduction
Cancer can be thought of as a complex ecosystem in which not only tumor
cells but also other cell types (phenotypes) may influence the overall health of
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an organism. Experimental results have recently shown that cancer cells may
mimic the functional features of normal cells (Kreso and Dick, 2014). The most
important features are associated with a small subpopulation of cells, namely
the stem cells. Stem cells (SCs) are defined to be cells with self-renewal capac-
ity and pluripotency. For instance, they can replenish and regenerate the whole
epithelial cell population in normal tissues. It has been proposed that cancer
stem cells (CSCs) maintain invasive characteristics, such as (undesirable) multi-
potency and uncontrolled growth and tumor initiating capacity (Borovski et al,
2011; O’Brien et al, 2009; Reya et al, 2001; Sprouffske et al, 2013; Marjanovic
et al, 2013). The differentiated progenies of SCs are the cells with specialized
distinct functions, within the organism. They are produced via a hierarchical
division scheme. As the differentiated cells (DCs) become more mature along
the hierarchy, their replication potential decreases (Chaffer et al, 2011a; Legrav-
erend and Jay, 2011; Magee et al, 2012; Ritsma et al, 2014).
CSCs reside in small niches and manifest characteristics similar to somatic
SCs (Borovski et al, 2011). In solid cancers, CSCs are usually imputed as a
result of the expression of similar biomarkers as those used to identify SCs
(Ginestier et al, 2007; Natarajan and FitzGerald, 2007; Singh et al, 2003; Bao
et al, 2006; Woodward and Sulman, 2008). In colon cancer, the over–expression
of the polycomb ring finger oncogene BMI1 leads to the down–regulation of
proteins p16INK4a and p14ARF. These proteins override cellular proliferation
restriction and generate cancer SLCs (Dimri et al, 2002; Legraverend and Jay,
2011; Marjanovic et al, 2013). For mammary stem cells, CD44+ and CD24− are
reported as markers for stemness. In acute–myeloid leukemia (AML) CD34+
CD38− cells are a leukemia–initiating subpopulation(Marjanovic et al, 2013;
Roesch et al, 2010).
Despite the new established dogma that cancer cells originate from a small
niche of cells (Marjanovic et al, 2013; Ritsma et al, 2014; Vermeulen et al, 2013),
a range of experiments have now investigated and reported on the cancer initiat-
ing capacity of committed progenitor cells (O’Brien et al, 2009; Li and Laterra,
2012; Marjanovic et al, 2013). In other words, non-SCs can undergo a dediffer-
entiation process and regain stemness (these cells are also called stem like cells).
In breast cancer, epithelial–mesenchymal transition (EMT) factors have been
implicated in the production of stem like cells from non–stem cells (Mani et al,
2008; Chaffer et al, 2011b, 2013). Gupta et al (Gupta et al, 2011) have also
observed that the epithelial differentiated cells with basal markers can convert
to cells with stem cell markers (see also (Chaffer et al, 2011b)). There are sev-
eral other experimental observations supporting dedifferentiation of committed
progenitor cells (Cabrera et al, 2015; Huels and Sansom, 2015; Li and Laterra,
2012; Marjanovic et al, 2013; Philpott and Winton, 2014). In addition, this ded-
ifferentiation has been observed, under certain microenvironmental conditions,
in normal SCs (Kreso and Dick, 2014; Tata et al, 2013; Dorantes-Acosta and
Pelayo, 2012). In fact, it is becoming apparent that cellular trans–differentiation
is activated in a number of organs to produce stem like cells in support of SCs
in tissue regeneration (Kreso and Dick, 2014; Li and Laterra, 2012; Marjanovic
et al, 2013; Vermeulen et al, 2013; Chaffer et al, 2011a; Fausto, 2000; Fillmore
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and Kuperwasser, 2008; Legraverend and Jay, 2011).
A variety of quantitative approaches have been utilized to investigate the
effect of the stem cell hierarchy and phenotypic heterogeneity on tumor growth
(Clayton et al, 2007; Dhawan et al, 2014; Turner et al, 2009; Zapperi and
La Porta, 2012; Gao et al, 2013). In the context of cancer evolution, the de-
terministic population dynamics of the stem cell hierarchy in the absence of
plasticity, is discussed by Werner et al (Werner et al, 2011, 2013). Plasticity
and dedifferentiation is explored under a diffusion approximation (Jilkine and
Gutenkunst, 2014) and replicator equation (Kamran Kaveh, 2013).In (Shahri-
yari and Komarova, 2013), the authors discuss the rate of evolution in a simple
hierarchical stem and non–stem cell population. They argue that stem cell
symmetric division is preferred under natural selection for two-hit mutations.
The evolutionary dynamics of malignant and normal genotypes in the pres-
ence of phenotypic transformations (differentiation and dedifferentiation) is not
well understood. In this study, we consider a general framework to study nat-
ural selection in heterogeneous populations. We analyze competition between
resident and mutant populations which are genotypically different. Each of
these types divide into phenotypically different subpopulations (stem cell and
differentiated subtypes). Due to homeostasis, the size of SC and DC subpopu-
lations are assumed to remain constant. Stem cells can self–renew and replenish
their own population or contribute to differentiated cell population via differ-
entiation events. Differentiated cells can also divide into differentiated cells or
dedifferentiate into stem like cell states.
We investigate conditions for the successful selection of a malignant muta-
tion in this complex population structure. Due to the plastic nature of the
early malignant progenitors, there is a finite chance for an advantageous mu-
tant to exit the differentiated group and become part of the SC niche. We
derive analytic results that predict the fixation probability of a mutant (either
in the SC or DC subpopulations) to establish a finite colony. We assume ar-
bitrary population sizes and division rates and selection intensities as well as
(de)differentiation rates. The analytic results are in excellent agreement with
stochastic simulations in finite populations. We apply our findings to colorectal
cancer and predict dedifferentiation rates that can confer a selection advantage
for p53 mutants.
The paper is organized as follows: in the Material and Methods section,
the generalized Moran process is defined and the generating function method
to calculate long-term fixation or extinction probabilities is presented. The
replicator dynamics for the model is derived in the absence of random drift. In
the Results section, we discuss the fixation probability as a function of stem
cell self-renewal rate, differentiation rate and dedifferentiation rate. The phase
diagrams for advantageous mutants are also presented towards the end of this
section. In the Discussion section, we summarize our findings and suggest some
possible generalizations to characterize more heterogeneous environments.
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Materials and Methods
Generalized Moran process with (a)symmetric division and plasticity
Consider two populations of resident or wild type (type 1) and mutant or in-
vader (type 2). Mutants are the result of an oncogenic mutation in the resident
population. Each genotype is divided into phenotypically different subpopula-
tions of stem cells (SC) and differentiated cells (DC). Stem cells can self-renew
symmetrically where the offspring are stem cells. They can differentiate (sym-
metrically or asymmetrically) to produce differentiated progenies of the same
genotype. We denote the probability of asymmetric differentiation (per divi-
sion) by uˆ1, uˆ2 and symmetric differentiation by vˆ1, vˆ2. The overall probability
of differentiation is u1,2 = uˆ1,2 + 2vˆ1,2. This is due to the fact that symmet-
ric differentiation produces two differentiated cells. Similarly the self-renewal
probability is denoted by 1−u1,2. The indexes 1 or 2 denote the corresponding
probabilities for a wild type or mutant. The division rate of a normal (or mu-
tant) stem cell is denoted by r1 (r2) respectively. Similarly, the division rates
of progenitors/differentiated cells are denoted by rˆ1 and rˆ2. For evolutionary
Figure 1: Phenotypic–genotypic changes in individuals within a four– compart-
mental structure. We consider constant population sizes NS and ND for SCs and DCs
respectively. With respect to the finite Markov chain, we consider a generalized model to take
into account the competition between normal and malignant individuals in each of the SC and
DC subpopulations. Differentiation and dedifferentiation events connect the selection dynam-
ics between the two niches. In (a), all possible differentiation, dedifferentiation, and death
events with their corresponding rates are represented. The SC-DC compartmental structure
is depicted in (b) with the associated self–renewal and differentiation/plasticity possibilities.
dynamics we consider a birth-death (BD) Moran process as follows: At each
time step, an individual is chosen to reproduce proportional to its fitness within
the SC or DC compartments. If a normal (mutant) cell in the SC compartment
is chosen to reproduce, its offspring replaces a randomly chosen cell in the stem
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cell compartment with probability 1 − u1 (1 − u2). Otherwise, with probabil-
ity u1 (u2), the (differentiated) offspring replaces a randomly chosen cell in the
DC compartment. Similarly, if a differentiated cell is chosen to reproduce, its
offspring replaces another cell in the differentiated cell compartment with the
probability 1 − η. Alternatively, the offspring can dedifferentiate into a stem-
like cell and replace a randomly chosen individual in the stem cell compartment
with a rate η, where η = η1(η = η2) denote the dedifferentiation probability for
normal (mutant) DCs. For simplicity we assumed death rates of all types to be
equal and set this to unity.
Table 1: Model parameters.
Notation Description
NS, ND Total number of stem and differentiated cells
r1, r2 Net reproduction rate of wild type and mutant stem cells
r˜1, r˜2 Net reproduction rate of wild type and mutant differentiated cells
u1, u2 Asymmetric differentiation rate of normal and mutant stem cells
η1, η2 Dedifferentiation rate of normal and mutant differentiated cells
The above dynamics models the differentiation mechanism with an effective
asymmetric division with the probabilities u1, u2. Thus in the following we use
the terms differentiation (of stem cells) and asymmetric division interchange-
ably.
The above Moran process can be written as a continuous time process (1/N
is the duration of each time step for N = NS +ND)
1
N
∂p(nS, nD; t)
∂t
= W+S (nS − 1, nD) p(nS − 1, nD; t) +W−S (nS + 1, nD) p(nS + 1, nD; t)
+W+D (nS, nD − 1) p(nS, nD − 1; t) +W−D (nS, nD + 1) p(nS, nD + 1; t)
− (W+S (nS, nD) +W+D (nS, nD) +W−S (nS, nD) +W−D (nS, nD)) p(nS, nD; t).
(1)
where p(nS, nD; t) denotes the probability of having nS mutant stem cells and
nD mutant differentiated cells, at time t (given n
0
S and n
0
D at t = 0). The
population of normal cells are given by NS − nS and ND − nD correspondingly.
The probabilities W±S and W
±
D are the transition probabilities corresponding
to an increase or decrease by one in the number of mutant SCs and DCs resp.
They are given by
W+S (nS, nD) = Prob(nS, nD → nS + 1, nD)
=
(
r2 (1− u2)nS + r˜2 η2 nD
Nr
)
NS − nS
NS
,
W−S (nS, nD) = Prob(nS, nD → nS − 1, nD)
=
(
r1 (1− u1) (NS − nS) + r˜1 η1 (ND − nD)
Nr
)
nS
NS
,
(2)
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W+D (nS, nD) = Prob(nS, nD → nS, nD + 1)
=
(
r˜2 (1− η2)nD + r2 u2 nS
Nr
)
ND − nD
ND
,
W−D (nS, nD) = Prob(nS, nD → nS, nD − 1)
=
(
r˜1 (1− η1) (ND − nD) + r1 u1 (NS − nS)
Nr
)
nD
ND
.
The denominator Nr denotes the total fitness of SC and DC individuals:
Nr = r1 (NS − nS) + r2 nS + r˜1(ND − nD) + r˜2 nD. (3)
The above Markov process has two absorbing states corresponding to fixation or
extinction of the mutant or WT. The competition between the two genotypes
in the stem cell compartment is tied to the competition inside the differenti-
ated compartment via differentiation and dedifferentiation mechanisms. In the
absence of plasticity we have a hierarchical population structure where only
mutations in the stem cell compartments can give rise to fixation in the whole
population.
In the next section, we present analytic solutions for the probability of fixa-
tion, of an invading mutant as a function of division rates and (de)differentiation
rates. Our calculations match with simulation results for a wide range of pa-
rameters and population sizes.
Fixation probability in a heterogeneous Moran process
One of the most important questions to address within a heterogeneous
population is the chance of success for a mutation in different subtypes.
The fixation probability of a mutant originating in the stem cell compart-
ment, ρS or the differentiated cell compartment, ρD is a measure of the tumor
initiating capacity of each subpopulation. For a completely hierarchical popu-
lation, only mutants that arise in the stem cell niche have a chance of fixating
in the whole population thus ρS = ρ. If the progenitors can dedifferentiate into
stem-like cells, the comparison between the two fixation probabilities, (ρS and
ρD), is a good measure of how the tumor initiating capacity correlates with the
notion of stemness.
The use of the probability generating function (PGF) method to study a con-
stant population Moran process is discussed in (Houchmandzadeh and Vallade,
2010, 2011; Kaveh et al, 2015). It is used to present an alternative derivation
of the (well-mixed) Moran fixation probability, by identifying a martingale for
the process. Here we generalize this technique for a heterogeneous population
under selective pressure in the presence of phenotypic plasticity.
A martingale for the above four population model, Eqs. (1), (3), can be
written as
〈(z?S)nS(z?D)nD〉, (4)
where 〈·〉 denotes the stochastic average and the (auxiliary) variables z?S and z?D
satisfy the following system of algebraic equations
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(z?S − 1) [r2(1− u2) z?S − r1(1− u1)− r˜1 η1] + (z?D − 1) z?S r2 u2 = 0 (5)
(z?D − 1) [r˜2 (1− η2) z?D − r˜1 (1− η1)− r1 u1] + (z?S − 1) z?D r˜2 η2 = 0.
By matching the initial conditions for t = 0 and the steady state solutions
of the PGF, we can obtain analytic expressions for the fixation probability
of mutants of each subtype (stem or differentiated). In general, the fixation
probability beginning with i mutant SCs and j mutant progenitors is (See SI
for details)
ρij =
1− (z?S)i (z?D)j
1− (z?S)NS (z?D)ND
. (6)
For i = 1 and j = 0 (starting with one initial SC mutant) the fixation probability
is
ρS ≡ ρ10 = 1− z
?
S
1− (z?S)NS (z?D)ND
. (7)
Similarly, the fixation probability of a newborn mutant in the DC compartment
(i = 0, j = 1) is
ρD ≡ ρ01 = 1− z
?
D
1− (z?S)NS (z?D)ND
. (8)
Moreover, assuming random mutations, i.e. uniform mutation rates in both
compartments, the average fixation probability is given by
ρ =
1− (NS/Ntot)z?S − (ND/Ntot)z?D
1− (z?S)NS (z?D)ND
. (9)
with Ntot = NS + ND. The probability of a successful emergent mutant before
time t (from a background of Ntot normal cells) is given by
P (t) = 1− e−Ntot·µρt, (10)
where µ denotes the mutation rate.
Stochastic simulation
Using the model described above, we performed numerical simulations using
such updates until each of the runs tends to saturation in the fraction of SCs
and DCs, or until we reach the maximum updating time of T=15,000 for each
realization. Then running the whole procedure for 20,000 realizations, we calcu-
lated the fraction of results for the fixation probability of SCs and DCs in those
runs. Then repeating each calculation for a set of five iterations, we calculated
the mean and error bars. Errors are calculated as the standard deviation of the
mean.
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Replicator equation
The Markov process considered in our four–compartment model exhibits
deterministic dynamics in the absence of stochastic fluctuations, i.e. infinite
population limit. This replicator equation captures the average frequency of
various phenotypes which provides insight into the evolutionary dynamics of
the system. Firstly, we detect the frequency of each phenotype at the fixed
points and secondly, analyze the phase diagram by varying different parameter
values (see the Results Sec.) at equilibrium. Starting from the master equation
(1), one obtains the following system of deterministic equations for malignant
SCs and DCs (see SI for derivation)
dxS
dt
=
[r2 (1− u2)− r1 (1− u1)]xS (1− xS) + r˜2 η2 xD (1− xS)− r˜1η1 xS (1− xD)
r1 (1− xS) + r2 xS + r˜1 (1− xD) + r˜2 xD ,
dxD
dt
=
[r˜2 (1− η2)− r˜1 (1− η1)]xD (1− xD) + r2 u2 xS (1− xD)− r1 u1 xD (1− xS)
r1 (1− xS) + r2 xS + r˜1 (1− xD) + r˜2 xD ,
(11)
where xS = 〈nS(t)/NS〉 and xD = 〈nD/ND〉 are the average frequencies of mu-
tant SCs and DCs resp. Stationary state frequencies, x?S and x
?
D satisfy the
following coupled system of equations
[r2 (1− u2)− r1 (1− u1)]x?S (1− x?S) + r˜2 η2 x?D (1− x?S)− r˜1η1 x?S (1− x?D) = 0,
[r˜2 (1− η2)− r˜1 (1− η1)]x?D (1− x?D) + r2 u2 x?S (1− x?D)− r1 u1 x?D (1− x?S) = 0.
(12)
In the next section, after obtaining the exact analytic form of the fixation prob-
ability for this generalized Moran process, we will use Eqs. (41) to derive the
condition for evolutionary advantage of the mutant genotype and the phase
diagram for the model.
Results
Exact analytic results for the fixation probability
We first begin with the analytic expressions for the survival probabilities
Eqs. (6)-(9) where z?S and z
?
D are the solutions of Eqs. (5). We begin with
some simpler limiting cases where compact algebraic results can be obtained,
and then proceed to general solutions of Eqs. (6)-(9).
Standard Moran process.. Let us consider the simple case where the differenti-
ation and dedifferentiation rates are set to zero. In this case our model should
reduce to two disjoint Moran processes, one for the stem cell and one for the
differentiated cell compartments.
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For this case, we obtain z?S = r1/r2 and z
?
D = r˜1/r˜2 and the fixation proba-
bility for a mutant to dominate a SC (DC) niche is
ρ1 =
1− r1r2
1−
(
r1
r2
)NS , ρ2 = 1− r˜1r˜2
1−
(
r˜1
r˜2
)ND . (13)
Another interesting limit that resembles a well-mixed Moran process in the stem
cell compartment occurs when r˜1,2 ' 0 but u1,2 6= 0. This is an exaggerated
case showcasing the limited proliferation capacity of differentiated progeny. The
corresponding average fixation probability for an emerged mutant in the SC or
DC compartment is
ρ =
NS
(
1− r1r2
)
Ntot
(
1−
(
r1
r2
)NS) , (14)
since the fixation probability of a newborn mutant in the DC class will be zero
in this case.
Invasion in hierarchical model (zero plasticity).. We now consider a more gen-
eral case with no plastic potential, η1,2 = 0. For the moment, we assume
r1 = r˜1 = 1, r2 = r˜2 = r.
ρS =
1− 1−u1r(1−u2)
1−
(
1−u1
r(1−u2)
)NS , ρD = 0, ρ = NSNtot ρS. (15)
Fig. 2 shows how the survival chance of an initial mutant SC varies in terms of
the relative fitness of mutant SCs/DCs as well as the probability of asymmetric
division in the SC compartment. The population size is set to NS = ND =
10. The results are plotted for three sets of differentiation rates (u1 = u2 =
0.5), (u1 = 0.1, u2 = 0.5) and (u1 = 0.5, u2 = 0.1) as r varies (Fig. 2(a)). If
the normal cell differentiation rate u1 is decreased from the balanced limit of
u1 = u2 = 1/2 the fixation probability decreases as well. Conversely, if the
mutant cell differentiation rate, u2 is decreased, away from u2 = 1/2, ρS would
increase.
We rewrite differentiation rates as u1 = u and u2 = u where u stands
for an overall measure of differentiation, in both genotypes, and  measures
the asymmetry in them. If  < 1 the normal type differentiates more often per
division and  > 1 indicates that invader cells differentiate more often. Fig. 2(b)
shows ρS for  = 1/2 as a function of u for several division rates, r = 1, 1.2, 1.5, 2.
For high differentiation rates, u, the fixation probability converges to unity. This
is consistent with Eq. (15). The relative fitness of the mutant versus normal
types are given by r(1 − u2)/(1 − u1) = r(2 − u)/(2(1 − u)). As u → 1 the
relative fitness approaches infinity and thus the value of fixation probability
tend to unity.
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Figure 2: The fixation probability of mutants in the absence of plasticity. We
assume NS = ND = 10, r1 = r˜1 = 1, and η1 = η2 = 0 in simulations (points) and analytic
calculations (solid lines). Each error bar shown at each point is the standard deviation of
mean. In (a) changing parameters u1, u2, that are the differentiation rates of normal and
tumor SCs resp., the trends for the fixation probability of mutants is given as a function of
relative fitness of mutants, referred to as r2 = r˜2 = r. In (b) and (c) the fixation probability
variation is given in terms of asymmetric differentiation rates u1 = u2 = u and various values
of r and the ratio of the differentiation rates of normal SCs  = u2/u1. In (b)  = 0.5 and in
(c)  = 1.5.
Similar results are plotted for  = 3/2 in Fig. 2(c). Now ρ approaches zero
for large u. Again this can be seen since r(1−u2)/(1−u1) = r(2−3u)/(2(1−u))
which approaches zero as u goes to 2/3.
Invasion in the presence of plasticity (dedifferentiation).. Now we consider a
more general case with non-zero differentiation and dedifferentiation rates. As
before we set r1 = r˜1 = 1. We parameterize the fitness of mutant subtypes as
r2 = αr and r˜2 = βr. (α is different from the one introduced in the previous
figure.) The parameter r denotes the overall proliferation advantage of mutants
over normal cells.
Fig. 3 shows ρ as a function of r for various values of α and β. Fig. 3(a)
assumes plastic mutants only (η1 = 0, η = 0.5) whereas Fig. 3(b) assumes
equally plastic genotypes (η1 = η2). The differentiation rates are equal and set
to 1/2 for simplicity. As can be seen, the overall increase in r increases the
fixation probability monotonically in both cases. However, varying values of α
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Figure 3: The fixation probability of mutants in the presence of phenotypic plas-
ticity. We suppose that NS = ND = 10, r1 = r˜1 = 1, r2 = αr, and r˜2 = βr in the analytic
results (solid curves) and stochastic simulation (points with bars as the standard deviation
of mean). Changing α from 0.5 to 1 and then to 2 while β remains fixed, the behavior
of the system is shown in terms of the fixation probability with respect to the relative fit-
ness r. In subfigure (a) plastic potential has only been considered for malignant individuals:
η1 = 0, η2 = 0.5 while in (b) both WT and mutant cells can dedifferentiate to the stemness
state (η1 = η2 = 0.5). Straightforward calculations reveal that for the given parameter values
in (b), ρ = ρS = ρD.
and β leads to the neutral value for the proliferation potential r. For example,
in the case of Fig. (a) for α = β = 1, i.e. r2 = r˜2 = r, the mutant is advantaged
for r > 0.75. For α = 0.5, β = 1, however, r > 1.25 has ρ > 1/N . Interestingly
if stem cells divide faster than progenitors, i.e. α > β, even for r ≈ 1/2 the
fixation probability is larger than the neutral value. We used the neutral fixation
probability as 1/NS = 1/ND = 1/10. Which is the neutral ρ in the absence of
(de)differentiation. Similar observations can be made in the case of η1 = η2
in part (b). As can be seen our results are in very good agreement with exact
stochastic simulations.
In Fig. 3, ρS is plotted as a function of r for several values of u1 and u2
(part (a)) as well as η (part (b)). The effect of dedifferentiation on increasing the
value of the fixation probability is most significant for r values corresponding
to the neutral limit (Fig. 3(b)) and Fig. 2(a). For example in Fig. 3(b) value
of ρ near r = 1 increases from approximately 0.1(≈ 1/N) to 0.3 as η increases
to 0.5 (from 0.01). However for r = 4 the difference between the two values of
ρ for η = 0.01, 0.5 is negligibly small.
In the presence of dedifferentiation, mutations arising in the differentiated
compartment can now undergo clonal expansion. In Fig. 5 we plotted values of
the fixation probabilities ρS, ρD and the average fixation ρ as a function of η. As
expected for η = 0, ρD tends to zero for various values of u1 and u2. However ρS
approaches the results obtained before (Eq. (15)). In Fig.5(a) for u1 = u2 = 0.5
and r = 1.1 ρS approaches 0.15 as η = 0. This is in agreement with the
extended Moran result, Eq. (15), with effective fitness r(1−u2)/(1−u1) which
for NS = 10 gives ρS = 0.15. As η increases ρS increases further and approaches
0.4 for large values of η. We can see that finite values of η have now conferred
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Figure 4: Effect of change in asymmetric differentiation and plasticity rates on
survivability of mutants. We assume thatNS = ND = 10, r1 = r˜1 = 1, and r2 = r˜2 = r. In
subfigure (a), the fixation probability of SCs as a function of η is given, where η = 0.01, 0.1, 0.5
while u1 = u2 = 0.5, and η1 = 0. In (b) η1 = 0 and η = 0.1. Changing parameters u1 and
u2, which are the asymmetric division rates of normal and tumor SCs resp., the fixation
probability as a function of u1, u2 is shown. Solid lines represent the analytic calculation and
points correspond to simulation results (error bars are based on the standard deviation of
mean).
a selection advantage on the previously deleterious mutants. For example for
u1 = 0.5, u2 = 0.1 and r = 1.1, the effective fitness is less than unity with
ρS ≈ 0. For finite values of the dedifferentiation rate, ρS will exceed the neutral
value 1/N . For example for η = 0.5 we can read ρS ≈ 0.25 in this case.
Phase diagram
To derive the phase diagram that determines the evolutionary advantage
of a malignant genotype, we begin with the system of equations (40). The
fixed points of the replicator equation determine the stationary frequencies of
mutant subtypes: x?S, x
?
D. There are four fixed–points for the system of equations
(40). The fixed point (x?S = 0, x
?
D = 0) corresponds to the extinction of both
phenotypes and other fixed points (x?S = 1, x
?
D = 1) or any (x
?
S 6= 0, x?D 6= 0)
corresponds to successful invasion by the mutant. We do not distinguish between
these fixed points as the stochastic fluctuations prohibit coexistence of mutant
and WT phenotypes. We determine the phase boundary when a fixed point
(x?S, x
?
D) merges with (0, 0). This indicates that the invasion has become unstable
to parameter changes, and determines the phase boundary in the phase space
of parameters.
Similar results can be obtained from the Eqs. (6)–(8) requiring that ρS =
1/NS (corresponding to the neutral selection). In a large population, this ap-
proach would be identical to the results from the replicator equation.
At first, we assume u1 = u2 = η1 = η2 = 0, then the solution to the system
(41) results in two fixed points, (x?S = 0, x
?
D = 0) (extinction) or (x
?
S = 1, x
?
D = 1)
(fixation) of invading mutant SCs (or DCs).
Next, we consider the case with r1 = r˜1 = 1, r2 = r˜2 = r, u1 = u2 = u,
η1 = 0, and η2 = η. We have plotted the phase diagram for the model parameter
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Figure 5: Effect of change in the rate of phenotypic plasticity for mutant DCs
on the survival probability of malignant cells. In subfigures (a), (b), and (c) we have
resp. considered the fixation probability of mutants while the initial malignant mutation resp.
occurs in SC, DC, and SC+DC compartments at random. In these plots, we assumed that
NS = ND = 10, r1 = r˜1 = 1, r2 = r˜2 = 1.1, u1 = 0.5 and η1 = 0. Different asymmetric
division rates of normal and malignant individuals have also taken into account when the
fixation probability is given as a function of η. Solid curves and points are respectively the
results of analytic and simulation analysis. At each given discrete point, the error bar depicts
the standard deviation of mean.
space of η − u − r. The phase boundary that determines the condition for
neutrality is given by the algebraic relation (see SI for details)
(u+ η − 1)r2 + [−u2 + (η − 1)u+ 2− η] r − 1 + u2 = 0, (16)
The phase diagram is plotted in the space of u − r (Fig. 6(a)) and η − r
(Fig.6(b)). The observation that an increase in η can turn a previously dele-
terious mutant into a beneficial one, can be seen here as well. For example in
Fig.6(b) for u = 0.7 and r = 0.9 < 1 where we expect a deleterious mutant for
large enough values of η, we can cross the phase boundary into an advantaged
region. Interestingly we observe a similar trend as the overall differentiation
rate increases.
Application to colorectal cancer
Clonal expansion in colorectal cancer is known to be initiated as a result of
mutations occurring at the bottom of the crypt (Vogelstein et al, 2013). More
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Figure 6: Phase diagram of plastic mutant SCs. The phase boundary for advan-
tageous and disadvantageous mutant populations are given as differentiation and plasticity
rates change. We assume that r1 = r˜1 = 1, r2 = r˜2 = r, u1 = u2 = u, and η1 = 0. Different
regions for advantageous and disadvantageous mutant SCs are given in (a) as u changes. A
similar analysis has been carried out in (b) as η varies. In (a) η = 0.1, 0.3, 0.7, here the alter-
ation in the plasticity rate of DCs results in a tendency to approach various regions of fixation
for mutant SCs, while the extinction domain shrinks with increasing η. In (b) u = 0.1, 0.3, 0.7.
Increasing the asymmetric division rate u, the region for advantageous mutants expands to
provide a higher survival chance for mutant SCs. In both cases, advantageous criteria relate
to either fixation of mutants or coexistence of mutants and WT individuals.
recently, Vermeulen et al (Vermeulen et al, 2013) considered the dynamics of
cells at the bottom of a normal colonic/intestinal crypt. Such controlled cells in
their circular model of size 5 undergo a selection process. The selection mecha-
nism is investigated for several oncogenes and tumor suppressor genes imposed
at the crypt base. Fixation probability of a single mutation and the relative fit-
ness r of the mutant cells, compared with the normal host, are reported. Their
estimates reveal that the relative fitness of the original cell containing APC−/−
is r = 1.58, while r = 1.56 for KrasG12D, and r = 0.96 for P53R172H (compared
with normal control cells mice). P53 mutation seems not to confer a fitness ad-
vantage and is weakly deleterious. However for P53R172H , it has been observed
that the fitness of a mutant elevates from 0.96 to 1.16 in comparison with the
DSS-treated cells (colitis) which is in the presence of inflammatory injury. Thus,
under inflammatory signaling effects, the P53R172H mutants appear to gain a
selection advantage and thus a higher fitness (Vermeulen et al, 2013, 2010).
According to the recent in vivo study by Schwitalla et al (Schwitalla et al,
2013), inflammatory signaling plays a role in elevating the rate of dedifferentia-
tion. It has been also shown that inflammatory disease activates the transcrip-
tion factor NF-κB. NF-κB can, in turn, elevate Wnt-signaling which leads to
the phenotypic plasticity of non-SCs (Karin and Greten, 2005).
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Thus we suggest that the higher survival chance of the P53 mutated SCs
along with the DSS-treated cells, may be the result of dedifferentiation in the
presence of inflammatory stroma (Schwitalla et al, 2013). The survival proba-
bility of mutants in colon/intestine, in the presence of inflammatory signaling, is
presumably correlated with both the fitness and plastic nature of the epithelial
cells. Thus the fixation probability reported in (Vermeulen et al, 2013) of cells
with P53 DSS colitis mutation, can be derived by the same fitness r = 0.96 for
P53 when dedifferentiation occurs.
For instance, when r = 0.96 and u1 = 0.5, u2 = 0.25, having the plasticity
rate at η = 0.12, one obtains the same fixation probability as (Vermeulen et al,
2013) (see Table 2). This finding strongly suggests that there is an elevation in
the fixation of a deleterious mutant into an advantageous trait due to the plastic
properties of the mutant (see also the next section). In Fig. 7, we considered a
cylindrical model of the crypt-base, and immediate adjoining transit amplifier
layers, cells in the colon/intestine. The bottom layer consists of central stem
cells and border stem cells, while transit ampflifying and non-SC cells reside
on top of this layer and at higher layers. A mouse crypt is comprised of 5–7
functional stem cells (Potten et al, 1992; Vermeulen et al, 2013). To compare the
results of our model with experimental observations of (Vermeulen et al, 2013)
for the fixation probability of P53 DSS colitis, we consider the first two circular
layers of SCs (see Fig. 7) in which we roughly assume NS ≈ 10 (Ritsma et al,
2014) and note that the fitness reported in the experimental data (Vermeulen
et al, 2013) is for functional SCs and may be considered unchanged for the two
layers (NS = 10) of central (functional) and border SCs as well.
Figure 7: Cellular interactions in the colonic crypt as a newborn mutant arises
within the Stem or differentiated compartments. Within this schematic cylindrical
model, we represent how our model is structured through the four compartments of host and
mutant stem and differentiated cells. In contrast to the circular model of five SCs considered
in (Vermeulen et al, 2010), we assume a cylindrical model of two circles, one on the top of
the other. SCs are located at the bottom circle while the circle on the top is full of partially-
differentiated cells.
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Table 2: Comparison between our analytic result and experiment (Vermeulen et al,
2013)
r η2 ρS Reference
P53 Controlled 0.96 0 0.113 (Vermeulen et al, 2013)
P53 DSS Colitis 1.16 0 0.343 (Vermeulen et al, 2013)
P53 DSS Colitis+Plasticity 0.96 0.12 0.343 Results Section
Discussion
The evolutionary implications of epigenetic heterogeneity are not very well
understood in cancer biology. A known picture for phenotypic heterogeneity
(when the genotypes are assumed to be identical) relates to the cancer stem
cell hierarchy. In this picture, pluripotent cells with tumor initiating capacity
can undergo mitotic events and either replenish their own population or pro-
duce a lineage of partially differentiated cells (including precursor and/or transit
amplifying cells).
In the current study, we present a general model of four distinct subpop-
ulations to investigate Darwinian evolution in such a hierarchical structure.
We consider two genotypically different populations (mutant and wild-type).
Mutations are results of unwanted oncogenic or TSG mutations. Each geno-
type has phenotypically different subtypes of stem cells (SCs) and differentiated
cells (DCs). SCs ultimately generate their associated progenies, DCs, through
proliferation and asymmetric differentiation. DCs have restricted proliferation
capacity. Due to the tissue structure of the crypt, the population of differ-
ent subtypes remains approximately unchanged. Genetic mutations can occur
among SCs or DCs which we assume to be occurring through a uniform prob-
ability. Mutations can confer not only higher division rates but also different
rates of differentiation and plasticity among mutant subtypes. These changes
can be triggered, for example, by microenvironmental conditions.
Our model predicts the fixation probability of a newborn mutant as a func-
tion of the division rates of mutant and resident SCs/DCs, differentiation and
dedifferentiation rates. Exact analytic calculation and numerical simulations –
which are in almost perfect agreement – suggest that the asymmetric differenti-
ation in the SC group has a major effect on the fate of mutants compared with
dedifferentiation. More specifically, a greater impact on the fixation probability
of SCs can be observed by the change in asymmetric differentiation of normal
cells compared with that of malignant cells. Furthermore, we observe that the
more plastic trait has an evolutionary advantage. This is most notable close to
the neutral limit, i.e. when the proliferation rates of the mutants and residents
are very close in value. Most interestingly, a sufficient increase in the rate of
plasticity can turn a previously deleterious mutant into a beneficial one.
As an important application of this model, we consider the intestinal/colonic
crypt with two groups of SCs and their neighboring, partially differentiated cells.
The competition between malignant mutations and normal cells in the base of
the crypt has attracted much research interest, and is one the most studied
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scenarios in cancer evolution. It has recently been shown that the Moran type
process, initially suggested by (Kaveh et al, 2016, 2015; Komarova, 2006, 2007;
Nowak, 2006; Nowak et al, 2002) are in perfect agreement with the experimen-
tal observation (Vermeulen et al, 2010). In this in vivo experimental analysis,
KRAS, APC+/−, APC−/−, and P53 DSS colitis mutations separately induced
in the crypt base. Assessing clonal lineage tracing (Vermeulen et al, 2010),
the authors were able to observe the growth of mutants in the populations and
thus measured the fixation probability of mutants. However, the experimental
observations sometimes ignore the microenvironmental interaction between the
neighboring transit amplifying (TA) cells and SCs in the crypt (See (Ritsma
et al, 2014; Vermeulen et al, 2010) for the models and estimated parameter
values of population dynamics of the crypt, as well as numbers of central and
border SCs at the base of the crypt).
In this investigation, we have suggested a plausible estimation method for
the dedifferentiation rate which can give the same value of the fixation probabili-
ties of P53 inactivation in the crypt base as observed by (Vermeulen et al, 2013).
As the authors in (Vermeulen et al, 2013) noticed, P53 mutations can maintain
advantageous features to invade the crypt base in the presence of inflammatory
signaling. We propose that this could potentially be a result of dedifferentia-
tion caused by an inflammatory stroma (Schwitalla et al, 2013). This finding
supports our idea about the elevation of a deleterious mutant into one with an
advantageous trait due to the plastic properties of the mutant.
This research is one of many mathematical approaches recently used to inves-
tigate various aspects of tumorigenesis. In our approach, we attempt to dissect a
part of the complex machinery in multi–compartmental models, and understand
this in greater detail. This study provides various insights concerning some fea-
tures of initiation and progression of cancer, and suggests possible experimental
investigations to confirm some of the theoretical results. The approach taken in
this paper may lead to a better understanding of the natural pathological mech-
anisms in the colonic/intestinal epithelium or any similar four–compartmental
structures in ecology, population genetics, and social networks. The particular
application of this approach to carcinogenesis may have some results at prog-
nosis.
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Supporting Information
A. Characteristic equation
Starting from the master equation of the given model (where for N = NS +
ND, we assume that 1/N is the duration of each updating time)
∂p(nS, nD; t)
N ∂t
= W+S (nS − 1, nD) p(nS − 1, nD; t) +W−S (nS + 1, nD) p(nS + 1, nD; t)
+W+D (nS, nD − 1) p(nS, nD − 1; t) +W−D (nS, nD + 1) p(nS, nD + 1; t)
− (W+S (nS, nD) +W+D (nS, nD) +W−S (nS, nD) +W−D (nS, nD)) p(nS, nD; t), (17)
the generating equation can be derived by assuming the probability generating
function (PGF) in which coefficients define the probabilities of being at different
possible states after a given time.
Starting from the master Eq. (17) discussed in the previous section, we can
analyze the probability of absorption (fixation or extinction) using generating
function techniques recently developed for the constant population birth-death
processes (Houchmandzadeh and Vallade, 2011). Defining the probability gen-
erating function (PGF) of the probability density function p(nS, nD; t) of having
nS mutant SCs and nD mutant DCs at time t. Then the PGF is
F (zS, zD; t) =
∑
nS,nD
znSS z
nD
D p(nS, nD; t) (18)
Using the PGF one can rewrite the master equation (the latter equation) for
PGF to derive the characteristic equations as follows
∂F
N ∂t
= (z−1S − 1)
〈
(W−S − zSW+S ) znSS znDD
〉
+ (z−1D − 1)
〈
(W−D − zDW+D ) znSS znDD
〉
, (19)
where the operators W±S and W
±
D are
W+S (nS, nD) = Prob(nS, nD → nS + 1, nD)
=
(
r2 (1− u2)nS + r˜2 η2 nD
r1 (NS − nS) + r2 nS + r˜1(ND − nD) + r˜2 nD
)
NS − nS
NS
,
W−S (nS, nD) = Prob(nS, nD → nS − 1, nD)
=
(
r1 (1− u1) (NS − nS) + r˜1 η1 (ND − nD)
r1 (NS − nS) + r2 nS + r˜1(ND − nD) + r˜2 nD
)
nS
NS
,
(20)
W+D (nS, nD) = Prob(nS, nD → nS, nD + 1)
=
(
r˜2 (1− η2)nD + r2 u2 nS
r1 (NS − nS) + r2 nS + r˜1(ND − nD) + r˜2 nD
)
ND − nD
ND
,
W−D (nS, nD) = Prob(nS, nD → nS, nD − 1)
=
(
r˜1 (1− η1) (ND − nD) + r1 u1 (NS − nS)
r1 (NS − nS) + r2 nS + r˜1(ND − nD) + r˜2 nD
)
nD
ND
.
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W±D (nS, nD) andW
±
D (nS, nD) define the transition probabilities for increase/decrease
in the number of mutant SCs and DCs resp. Acquiring these probabilities with
those for no change in the number of mutant cells in either compartments, one
can define the transition matrix which incorporates random walks among vari-
ous states prior to fixation.
Substituting Eqs. (20) into generating equation (19), we obtain:
∂F
N ∂t
=
〈 (z−1S − 1)(r2 (1− u2)nS + r˜2 η2 nD)(NS − nS)
(r1 (NS − nS) + r2 nS + r˜1(ND − nD) + r˜2 nD)NS
〉
+
〈 (1− zS)(r1 (1− u1) (NS − nS) + r˜1 η1 (ND − nD))nS
NS(r1 (NS − nS) + r2 nS + r˜1(ND − nD) + r˜2 nD)
〉
+
〈 (z−1D − 1)(r˜2 (1− η2)nD + r2 u2 nS)(ND − nD)
(r1 (NS − nS) + r2 nS + r˜1(ND − nD) + r˜2 nD)ND
〉
+
〈 (1− zD)(r˜1 (1− η1) (ND − nD) + r1 u1 (NS − nS))nD
(r1 (NS − nS) + r2 nS + r˜1(ND − nD) + r˜2 nD)ND
〉
(21)
Defining nˆS = zS
∂
∂zS
, nˆD = zD
∂
∂zD
, we conclude
∂F
N ∂t
=
{
(z−1S − 1)W−S (nˆS, nˆD) + (zS − 1)W+S (nˆS, nˆD)
+(z−1D − 1)W−D (nˆS, nˆD) + (zP − 1)W+D (nˆS, nˆD)
}
F. (22)
For large – NS (ND), we can simplify the latter equation for the probability
generating function by keeping the linear derivative terms to leading order in
NS (ND). This tends to
∂F
N ∂t
' (zS − 1)
{
r2(1− u2) zS ∂F∂zS + r˜2 η2 zS ∂F∂zD
Nˆr,S,D
− r1 (1− u1)NS
∂F
∂zS
+ r˜1 η1ND
∂F
∂zS
Nˆr,S,DNS
}
+(zD − 1)
{
r˜2(1− η2) zD ∂F∂zD + r2 u2 zS ∂F∂zS
Nˆr,S,D
− r˜1 (1− η1)ND
∂F
∂zD
+ r1 u1NS
∂F
∂zD
Nˆr,S,DND
}
, (23)
where the operator
Nˆr,S,P = r1 (NS − nˆS) + r2 nˆS + r˜1(ND − nˆD) + r˜2 nˆD, (24)
can be considered constant when NS and ND are set to be large, NS, ND  1.
Setting the coefficients of the derivatives ∂F∂zS and
∂F
∂zD
to zero, we obtain
approximate quasi-stationary points of this constant population dynamics at the
large–t limit. This relates to the corresponding martingales for NS, ND → ∞
branching process limit. Denoting the solutions with z?S and z
?
P, one attains
(z?S − 1) [r2(1− u2) z?S − r1(1− u1)− r˜1 η1] + (z?D − 1) zS r2 u2 = 0 (25)
(z?D − 1) [r˜2 (1− η2) z?D − r˜1 (1− η1)− r1 u1] + (z?S − 1) z?D r˜2 η2 = 0.
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B. Fixation probability
Taking advantage of the generating function, an exact analytic approach for
the fixation probability can be derived even in the presence of plasticity (when
mutation and mutation–back do not occur). The results are obtained for a BD
Moran process; however, a similar calculation can be performed for a Voter (DB)
Model with presumably different fixed points for the same initial conditions. The
boundary and initial conditions for the corresponding generating function are
resp. as follows
F (zS = 1, zD = 1, t) = 1, for any t > 0, (26)
F (zS, zD, t = 0) = z
i
S z
j
D, (27)
where i and j are the initial number of cancer SCs and DCs resp. For the
following special cases, the system has two absorbing states at equilibrium which
signify fixation and extinction for mutant cells in either compartments. We
denote the probability of reaching extinction and fixation states by B0 and B1
resp. Thus we obtain the following result from the PGF at steady state
F (zS, zD, t→∞) = p(nS = 0, nD = 0, t→∞)
+p(nS = NS, nd = ND, t→∞) zNSS zNDD
= B0 +B1 z
NS
S z
ND
d , (28)
based on the boundary condition (26), B0 + B1 = 1. Biologically, since the
mutant DCs are produced by cancer SCs, extinction of cancer SCs will result
in replenishment of mutant DCs. Moreover, the co-operation between SCs and
DCs suggests that it is impossible to have mutant SCs fixate while DCs become
completely extinct. We conclude that
F (zS, zD, t→∞) = 1−B1
(
1− zNSS zNDD
)
. (29)
Finally, applying the initial condition, F (zS, zD, t = 0) = z
i
S z
j
D and the
boundary condition, F (zS = 1, zD = 1, t) = 1, the fixation probability for an
initial population of i malignant stem cells and j progenitors is derived as
ρij =
1− (z?S)i (z?D)j
1− (z?S)NS (z?D)ND
, (30)
where (z?S, z
?
D) is the nontrivial fixed point of the generating Eq. (25).
C. Finding the quasi–fixed points and the associated survival probabilities
An interesting scenario occurs when the normal component is not plastic,
i.e. η1 = 0, in which case the above equations can be simplified to the following
expression of z?S, z
?
D 6= 1
z?D =
(
r1 (1− u2) (r˜1 + r1 u1)
)
z?S + r1 (1− u1) (r˜1 + r1 u1)(
r1 r2 (1− u2) (1− η1)− r˜2 r2 u2 η2
)
z?S − r1 r2 (1− u1) (1− η2)
.(31)
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Eqs. (5) can be reduced to the following closed form(
A− B
z?S
)(
E − F
z?D
)
= C .G, (32)
where
A = r2 (1− u2), B = r1 (1− u1) + r˜1 η1, C = r2 u2, (33)
E = r˜2 (1− η2), F = r˜1 (1− η1) + r1 u1, G = r˜2 η2.
The latter equations together with the original system suggest the following
solution for zS and thus represent another fixed point of the problem:
(A2E −ACG) (z?S)3 + (ACF + C2G+BCG+ACG− 2ABE −A2E −ACE) (z?S)2
+(B2E +BCE + 2ABE −BCG−BCF ) z?S = B2E. (34)
Now let us consider the following particular cases which give rise to some
interesting consequences of the model.
C1. Standard Moran process
Assume that there is no transition (migration) between SC and DC compart-
ments (two islands), that is, ui, ηj  1 for i, j = 1, 2. Then each compartment
will follow the mass–action BD Moran model with the fixed points for z?S and
z?D where the overall behavior is akin to two disjoint Moran processes. The
solutions to Eqs. (25) are
(1) z?S = 1, z
?
D = 1,
(2) z?S = 1, z
?
D =
r˜1
r˜2
,
(3) z?S =
r1
r2
, z?D = 1,
(4) z?S =
r1
r2
, z?D =
r˜1
r˜2
.
where the solution (4) accounts for the fixed points of two separated Moran
models in SC and Dc groups. Therefore, the fixation probabilities of starting
from one imposed mutant in SC and DC groups resp. are
ρ1 =
1− r1r2
1−
(
r1
r2
)NS , ρ2 = 1− r˜1r˜2
1−
(
r˜1
r˜2
)ND . (35)
Another interesting limit that results in a well-mixed Moran model in the SC
class occurs when r˜1,2 ' 0 where SCs are also committed to reach a stationary
state. Then the solutions to Eqs. (25) are given by
(1) z?S = 1, z
?
D = 1,
(2) z?S =
r1
r2
, z?D = 1.
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Compared with the result from the previous case, the second solution relates
to the solution of a well–mixed model occurring in the SC compartment where
the only absorbing state for mutant DCs is to take over the whole population
where the evolutionary scenario accounts for cancer DCs domination. In this
scenario, the average fixation probability is
ρ =
NS
(
1− r1r2
)
Ntot
(
1−
(
r1
r2
)NS) , (36)
C2. Invasion in hierarchical model (no plasticity)
Now we consider the case where no plastic potential is taken into account
during the whole process, we assume that r1 = r˜1 = 1, r2 = r˜2 = r, u1 = u2 = u,
and η1 = η2 = 0. in this situation, one obtains the following solutions
(1) z?S = 1, z
?
D = 1,
(2) z?S =
1
ueff
, z?D = 1
(3) z?S =
−r+u1+u2 u1−1+u2+Γ
2r(−1+u2) , z
?
D =
u1+1
r .
where ueff =
r(1−u2)
1−u1 is the effective asymmetric division rate and
Γ2 = 1− 6ru2u1 + u21 + 2ru2 − 2r − 2u2 − 2u1 + 2ru1 + r2 + 2u2u21 + 2u22
u1 + u
2
2 + u
2
2u
2
1. (37)
The third solution cannot be maintained in reality since there is no cooperation
between the compartments, which could result in support for the mutant SC by
the mutant DC group. In such a case, the only possible outcome would be the
fixation of the mutant DCs. Collectively, we find
ρS =
1− 1−u1r(1−u2)
1−
(
1−u1
r(1−u2)
)NS , ρD = 0, ρ = NSNtot ρS. (38)
C3. Invasion with phenotypic plasticity (dedifferentiation)
Suppose that dedifferentiation only occurs for the mutant DCs at a rate
η2 = η for η  η1 ≈ 0. Also let assume that r1 = r˜1 = 1, r2 = r˜2 = r,
u1 = u2 = u and η2 = η, then the solutions for z
?
S and z
?
D are
(1) z?S = 1, z
?
D = 1,
(2) z?S satisfies in the equation
(A2E −ACG) (z?S)3 + (ACF + C2G+BCG+ACG− 2ABE −A2E −ACE) (z?S)2
+(B2E +BCE + 2ABE −BCG−BCF ) z?S = B2E,
where A = r(1−u), B = 1−u, C = ru, E = r(1−η), F = u+ 1, G = rη,
and z?D =
(z?S+1)(1−u2)
r[(1−u−ruη)z?
S
−(1−u)(1−η)] .
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The values for z?S and z
?
D, in this case, satisfy the following relations (for more
details refer to Supplementary Information):(
A− B
z?S
)(
E − F
z?D
)
= C .G, z?D =
(z?S + 1)(1− u2)
r[(1− u− ruη)z?S − (1− u)(1− η)]
,(39)
where A = r(1− u), B = 1− u, C = ru, E = r(1− η), F = u+ 1, G = rη.
The derived solutions introduce the possible fixed points of the characteristic
equations. We investigate this case in more detail later and through analyzing
the phase diagram of the generalized model for non-zero plasticity in the repli-
cator dynamics.
D. Phase diagram of the system
Now, acquiring the replicator dynamics of the four compartment model
which depict the alterations in the the average frequencies of mutant SCs and
DCs, resp. xS = 〈nS(t)/NS〉 and xD = 〈nD/ND〉, one obtains the following
system of equations:
dxS
dt
≈ 〈W+S −W−S 〉
=
[r2 (1− u2)− r1 (1− u1)]xS (1− xS) + r˜2 η2 xD (1− xS)− r˜1η1 xS (1− xD)
r1 (1− xS) + r2 xS + r˜1 (1− xD) + r˜2 xD ,
(40)dxD
dt
≈ 〈W+D −W−D 〉
=
[r˜2 (1− η2)− r˜1 (1− η1)]xD (1− xD) + r2 u2 xS (1− xD)− r1 u1 xD (1− xS)
r1 (1− xS) + r2 xS + r˜1 (1− xD) + r˜2 xD .
At equilibrium, the fraction of mutant stem and non-stem cell groups would
lead to a specific states which are the pseudo–fixed points of the problem. These
type of fixed points can be attractive or repulsive, depending on the initial condi-
tions of the system. As we described in the paper, according to the cooperation
between mutant SCs and DCs (and similarly between normal SCs and DCs),
the malignant individuals may become extinct or survive together. Now defin-
ing the fixed point as (x?S, x
?
D), it may tend either to (0, 0) or to (1, 1). Such
a criteria suggests two distinct phases for the fate of the malignant cells which
are separated by the phase boundary. At steady state, the following system can
be derived for the fixed points x?S and x
?
D:
[r2 (1− u2)− r1 (1− u1)]x?S (1− x?S) + r˜2 η2 x?D (1− x?S)− r˜1η1 x?S (1− x?D) = 0,
(41)
[r˜2 (1− η2)− r˜1 (1− η1)]x?D (1− x?D) + r2 u2 x?S (1− x?D)− r1 u1 x?D (1− x?S) = 0.
To analyze the latter system, we may consider two important cases:
Case 1.. At first, we assume u1 = u2 = η1 = η2 = 0, then the solutions to the
system (41) results in the extinction or fixation of mutant SCs and DCs. In
this case, the phase diagram is simply divided to two advantageous (r > 1) and
disadvantageous (r < 1) cases.
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Case 2.. Suppose that r1 = r˜1 = 1, r2 = r˜2 = r, u1 = u2 = u, η1 = 0, and
η2 =: η. This introduces an interesting scenario in which plasticity occurs
only for the cancerous cells but not for the WT individuals. These restrictions
simplify system (41) to the following possible cases for x?S and x
?
D
(1) x?S = 0, x
?
D = 0,
(2) x?S = 1, x
?
D = 1,
(3) x?S = 1, x
?
D =
r u
1−r+r η , and
(4) x?S = r ηAM−11 , x?D = AM−12 ,
where
M1 = 3ru2 + 3r + 2u− 3r2u2 + 6r2u− 6ru− rη − 2r3u− 2r2ηu+ rηu+ 2r2η
+r3ηu− 3r2 + r3 + r3u2 − r3η − 1− u2,
(42)
M2 = r2u+ r2η − r2 − 2ru− rη + 2r − 1 + u,
A = 2r − 1− rη + r2u+ r2η + u2 − ru− r2 + rηu− ru2.
Among the given solutions (1)-(4) of the present case, the only acceptable
non–trivial solution is (4). The solution (3) does not satisfy the condition 0 ≤
xD ≤ 1 for all possible values of r, u, and η. Moreover, as we described above,
the cooperation among mutant cells results in the fixation of both mutant SC
and DC groups to the state (1, 1).
The last solution, then, implies that having (xS, xD) → (0, 0) leads to the
following solution
A = (u+ η − 1)r2 + [−u2 + (η − 1)u+ 2− η] r − 1 + u2 = 0, (43)
which characterizes the advantageous and disadvantageous regions for mutants
(see Fig. (6) for more details). Another limit relates to the case where (xS, xD)
approaches (1, 1). One obtains
r η = (r − 1)(u− 1) (44)
This condition, which is not defined for r > 1, does not change the phase
diagram and would not have any effect on the selection pressure of the system
on mutants.
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